Mitochem Therapeutics ^Company

MitoChem Therapeutics is a privately held company developing mitochondrial targeted small molecules for ophthalmic and neurodegenerative diseases. Mitochem has used high-throughput screening and sophisticated secondary assays, medicinal chemistry optimization and computational strategies to develop small molecules that protect mitochondria that are undergoing the stress that drives neuropathologies and diseases.